A New Route to Substituted Pyrimido[5,4-e]-1,2,4-triazine-5,7(1H,6H)-diones and Facile Extension to 5,7(6H,8H) Isomers.
A new route to substituted pyrimido[5,4-e]-1,2,4-triazine-5,7(1H,6H)-diones is outlined. The synthesis proceeds via pre-formed hydrazone intermediates, which are then condensed with an activated chlorouracil to build up the entire molecular framework, followed by a reductive ring closure to provide the parent series. The route has been extended to the isomeric pyrimido[5,4-e]-1,2,4-triazine-5,7(6H,8H)-dione class via the use of methylhydrazine as hydrazine surrogate, followed by regiospecific alkylation of the N(8)-H pyrimidotriazinediones with a range of alkyl and alkaryl substituents. This new methodology permits the generation of a wide range of compounds with variable substitution at the N(1), C(3), and N(8) positions for a heterocyclic scaffold with demonstrated pharmacological activity.
Department of Medicinal Chemistry, University of Michigan, Ann Arbor, MI 48109-1065, USA.
Anjanette J
AJ
Turbiak
H D
HD
Hollis Showalter
J Med Chem. 2007 Apr 19;50(8):1993-7
17385848
Chem Pharm Bull (Tokyo). 1993 Feb;41(2):362-8
8500202
J Chem Soc Perkin 1. 1976;(7):713-5
944191
J Biol Chem. 1966 Feb 25;241(4):846-52
5905124
Chem Pharm Bull (Tokyo). 1975 Sep;23(9):2001-9
171091
J Org Chem. 2008 Mar 21;73(6):2412-5
18278943
Tetrahedron Lett. 2009 Apr 29;50(17):1996-1997
21643441
J Org Chem. 1966 Mar;31(3):900-2
5907865